Is the cytomegalovirus serologic status always accurate? A comparative analysis of humoral and cellular immunity1
- 27 October 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 76 (8) , 1229-1231
- https://doi.org/10.1097/01.tp.0000083894.61333.56
Abstract
The precise knowledge of cytomegalovirus (CMV) status is important in a variety of clinical settings such as transplantation or blood transfusion. There are, however, various situations where an immunoglobulin-based diagnostic approach has limitations. The CMV status of 388 individuals was determined by the analysis of both CMV-specific immunoglobulins and cellular immunity using a standard enzyme-linked immunosorbent assay and a rapid-flow cytometric approach, respectively. In 386 of 388 individuals, both assays yielded concordant results in assigning the CMV status (294 positive and 92 negative). In 2 of 94 (2.1%) CMV immunoglobulin (Ig) G-negative individuals, CMV-specific CD4 T cells were detectable. Repeated testing of the index and follow-up samples yielded one positive and one marginally positive IgG titer. Both assays yielded highly concordant results. Thus, the T-cell-based approach may represent a reliable alternative for defining CMV status in any clinical situation where serologic testing is limited by borderline titers or by the presence of passively administered antibodies.Keywords
This publication has 10 references indexed in Scilit:
- Reassessing the impact of cytomegalovirus infection in kidney and kidney-pancreas transplantationAmerican Journal of Kidney Diseases, 2002
- Sustained High Frequencies of Specific CD4 T Cells Restricted to a Single Persistent VirusJournal of Virology, 2002
- RISK FACTORS AND IMPACT OF CYTOMEGALOVIRUS DISEASE IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANTATIONTransplantation, 2001
- LEVELS OF VIRUS-SPECIFIC CD4 T CELLS CORRELATE WITH CYTOMEGALOVIRUS CONTROL AND PREDICT VIRUS-INDUCED DISEASE AFTER RENAL TRANSPLANTATION1Transplantation, 2001
- Viral mechanisms of immune evasionImmunology Today, 2000
- Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal TransplantationNew England Journal of Medicine, 1999
- Infection in Organ-Transplant RecipientsNew England Journal of Medicine, 1998
- Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the DonorNew England Journal of Medicine, 1995
- Blutspenderauswahl zur Bereitstellung von anti-Cytomegalievirus-negativen BlutkomponentenDeutsche Medizinische Wochenschrift (1946), 1989
- THE ROLE OF PRETRANSPLANT IMMUNITY IN PROTECTION FROM CYTOMEGALOVIRUS DISEASE FOLLOWING RENAL TRANSPLANTATIONTransplantation, 1985